Company

Pharmocann Global Ltd

Headquarters: Kiryat Tivon, Israel

CEO: Mr. Gil Paramedic

TASE: PMCN -1.33%

Market Cap

₪7.7 Million

ILS as of Jan. 1, 2023

US$2.2 Million

Market Cap History

Pharmocann Global Ltd market capitalization over time

Evolution of Pharmocann Global Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Pharmocann Global Ltd

Detailed Description

Pharmocann Global Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes. The company provides TAVOR, JERUSALEM, CARMEL, CANAAN, MERON, HERMON, and MEGIDO for treatment of depression, insomnia, migraines, chronic pain, sleeplessness, post trauma, anxiety, combat stress, crohn's disease, indigestion, fatigue, cancer, chemotherapy, alzheimer, multiple sclerosis, arthritis, sleeplessness, pain, lack of appetite, and muscular dystrophy. It produces 3.5 tons of medical cannabis yearly and serves Israel, Australia, Asia, Europe, the United States, Canada, and internationally. It also produces and distributes hemp seed oil products. The company was formerly known as Medical Compression System (DBN) Ltd. and changed its name to Pharmocann Global Ltd. Pharmocann Global Ltd was incorporated in 1997 and is headquartered in Kiryat Tivon, Israel.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Pharmocann Global Ltd has the following listings and related stock indices.


Stock: TASE: PMCN wb_incandescent

Details

Headquarters:

Ramat Yishai

PO Box 305

Kiryat Tivon, 3601201

Israel

Phone: 972 4 953 3757

Fax: 972 4 953 3756